Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Study reveals what drives PFAS exposure in firefighters and how risks may be reduced

4

Feb 2026

Study reveals what drives PFAS exposure in firefighters and how risks may be reduced

A large U.S. firefighter cohort study identified personal, occupational, and department-level predictors of serum PFAS concentrations, highlighting both modifiable exposures and persistent background sources. Some protective practices, blood or plasma donation, and drinking water sources were associated with differences in specific PFAS analytes, although causal relationships require further longitudinal study.

Post-thrombectomy alteplase linked to better stroke outcomes

4

Feb 2026

Post-thrombectomy alteplase linked to better stroke outcomes

Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the number of patients who fully recover, according to preliminary late-breaking science presented at the American Stroke Association's International Stroke Conference 2026.

DNA marker reveals pyrethroid resistance in malaria mosquitoes

4

Feb 2026

DNA marker reveals pyrethroid resistance in malaria mosquitoes

A new study, jointly led by Liverpool School of Tropical Medicine and the Centre for Research in Infectious Diseases (CRID) in Cameroon, has detected a DNA marker in a gene encoding for a key enzyme, known as cytochrome P450, that helps mosquitoes to break down and survive exposure to pyrethroids, the main insecticides used for treating bed nets.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.